Tenaya Therapeutics, Inc. · NASDAQ:TNYA

Tenaya Therapeutics, Inc. financial statements

Tenaya Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue0000000
Cost of revenue8.44M8.47M8.69M8.71M4.03M2.48M1.99M
Gross profit-8.44M-8.47M-8.69M-8.71M-4.03M-2.48M-1.99M
Research and development68.6M86.7M98.0M94.5M54.4M31.1M23.1M
Selling, general and administrative24.7M29.2M33.2M31.1M18.4M7.81M4.56M
Operating income-93.3M-115.9M-131.2M-125.6M-72.8M-38.9M-27.7M
Depreciation and amortization8.44M8.47M8.69M6.47M2.96M2.48M1.99M
EBITDA-84.9M-107.5M-122.5M-119.2M-69.8M-36.4M-25.7M
Interest expense1.96K72.7M00
Income before tax-90.6M-111.1M-124.1M-123.7M-72.7M-38.4M-26.2M
Income tax000000-453.0K
Net income-90.6M-111.1M-124.1M-123.7M-72.7M-38.4M-25.8M
Earnings per share, basic-0.59-1.31-1.68-2.76-4.10-39.50-0.95
Earnings per share, diluted-0.59-1.31-1.68-2.76-4.10-39.50

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents100.5M4.32M45.7M95.3M38.1M128.5M23.9M
Short-term investments057.1M59.0M91.3M213.2M02.75M
Receivables2.25M
Inventory-19.9M
Current assets105.6M67.4M111.6M193.8M255.4M130.0M27.7M
Property, plant and equipment27.7M35.9M43.3M51.0M43.0M17.2M9.57M
Total assets146.9M119.9M170.5M278.9M314.2M148.2M38.0M
Accounts payable3.58M5.16M5.63M9.58M10.7M1.02M600.0K
Current liabilities15.4M16.0M22.7M24.2M21.8M5.04M4.12M
Total debt10.8M13.6M12.4M15.1M15.7M
Total liabilities23.7M27.1M31.1M35.6M35.7M8.72M81.7M
Shareholders' equity123.3M92.9M139.4M243.4M278.5M-81.3M-43.7M
Shares outstanding216.8M86.5M68.3M66.9M41.3M1.21M27.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-68.3M-90.5M-102.1M-104.4M-60.8M-35.4M-24.1M
Capital spending-618.0K-1.02M-1.24M-20.6M-25.1M-9.76M-2.93M
Free cash flow-68.9M-91.5M-103.3M-125.1M-85.9M-45.2M-27.0M
Cash from investing56.1M1.13M48.7M83.7M-238.6M-7.01M-5.58M
Cash from financing108.4M47.7M4.05M77.8M209.0M147.3M30.5M
Share buybacks77.8M-13.0K-1.00K-3.00K
Change in cash96.2M-41.6M-49.3M57.0M-90.4M104.8M832.0K